IRIS Accounts Production v24.3.0.553 09923907 Board of Directors Board of Directors 1.4.23 31.3.24 31.3.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh099239072023-03-31099239072024-03-31099239072023-04-012024-03-31099239072022-03-31099239072022-04-012023-03-31099239072023-03-3109923907ns15:EnglandWales2023-04-012024-03-3109923907ns14:PoundSterling2023-04-012024-03-3109923907ns10:Director12023-04-012024-03-3109923907ns10:Director22023-04-012024-03-3109923907ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3109923907ns10:SmallEntities2023-04-012024-03-3109923907ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3109923907ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3109923907ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3109923907ns10:FullAccounts2023-04-012024-03-3109923907ns10:RegisteredOffice2023-04-012024-03-3109923907ns5:CurrentFinancialInstruments2024-03-3109923907ns5:CurrentFinancialInstruments2023-03-3109923907ns5:Non-currentFinancialInstruments2024-03-3109923907ns5:Non-currentFinancialInstruments2023-03-3109923907ns5:ShareCapital2024-03-3109923907ns5:ShareCapital2023-03-3109923907ns5:RetainedEarningsAccumulatedLosses2024-03-3109923907ns5:RetainedEarningsAccumulatedLosses2023-03-3109923907ns5:FurnitureFittings2023-04-012024-03-3109923907ns5:ComputerEquipment2023-04-012024-03-3109923907ns5:FurnitureFittings2023-03-3109923907ns5:ComputerEquipment2023-03-3109923907ns5:FurnitureFittings2024-03-3109923907ns5:ComputerEquipment2024-03-3109923907ns5:FurnitureFittings2023-03-3109923907ns5:ComputerEquipment2023-03-3109923907ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3109923907ns5:WithinOneYearns5:CurrentFinancialInstruments2023-03-31099239071ns10:Director12023-03-31099239071ns10:Director12022-03-31099239071ns10:Director12023-04-012024-03-31099239071ns10:Director12022-04-012023-03-31099239071ns10:Director12024-03-31099239071ns10:Director12023-03-3109923907ns10:Director222023-03-3109923907ns10:Director222022-03-3109923907ns10:Director222023-04-012024-03-3109923907ns10:Director222022-04-012023-03-3109923907ns10:Director222024-03-3109923907ns10:Director222023-03-31
REGISTERED NUMBER: 09923907 (England and Wales)










CROSSROADS CLINIC LTD

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024






CROSSROADS CLINIC LTD (REGISTERED NUMBER: 09923907)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


CROSSROADS CLINIC LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2024







DIRECTORS: Mrs S E Haycock
Mrs E Protheroe





REGISTERED OFFICE: Ground Floor Cardigan House
Castle Court
Swansea Enterprise Park
Swansea
SA7 9LA





REGISTERED NUMBER: 09923907 (England and Wales)





ACCOUNTANTS: Bevan Buckland LLP
Ground Floor Cardigan House
Castle Court
Swansea Enterprise Park
Swansea
SA7 9LA

CROSSROADS CLINIC LTD (REGISTERED NUMBER: 09923907)

BALANCE SHEET
31 MARCH 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,158 1,236

CURRENT ASSETS
Debtors 5 44,551 29,126
Cash at bank and in hand 2,913 4,893
47,464 34,019
CREDITORS
Amounts falling due within one year 6 26,448 18,030
NET CURRENT ASSETS 21,016 15,989
TOTAL ASSETS LESS CURRENT
LIABILITIES

22,174

17,225

CREDITORS
Amounts falling due after more than one year 7 14,155 17,024
NET ASSETS 8,019 201

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 7,919 101
SHAREHOLDERS' FUNDS 8,019 201

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

CROSSROADS CLINIC LTD (REGISTERED NUMBER: 09923907)

BALANCE SHEET - continued
31 MARCH 2024



The financial statements were approved by the Board of Directors and authorised for issue on 21 October 2024 and were signed on its behalf by:




Mrs S E Haycock - Director



Mrs E Protheroe - Director


CROSSROADS CLINIC LTD (REGISTERED NUMBER: 09923907)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

1. STATUTORY INFORMATION

Crossroads Clinic Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% reducing balance
Computer equipment - 33% straight line

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

CROSSROADS CLINIC LTD (REGISTERED NUMBER: 09923907)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024

2. ACCOUNTING POLICIES - continued

Cash at bank and cash in hand
Cash at bank and cash in hand includes cash and short term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.

Debtors
Trade and other debtors are recognised at the settlement amount due after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.

Creditors and provisions
Creditors and provisions are recognised where the company has a present obligation (legal and constructive) resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discounts due.

Financial Instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Impairment of Financial Assets
Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset's original effective interest rate. The impairment loss is recognised in profit or loss

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of Financial Liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities
Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

CROSSROADS CLINIC LTD (REGISTERED NUMBER: 09923907)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024

2. ACCOUNTING POLICIES - continued

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Derecognition of financial liabilities
Financial liabilities are derecognised when the company's contractual obligations expire or are discharged or cancelled.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 5 (2023 - 5 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 April 2023 5,498 778 6,276
Additions 390 169 559
At 31 March 2024 5,888 947 6,835
DEPRECIATION
At 1 April 2023 4,591 449 5,040
Charge for year 308 329 637
At 31 March 2024 4,899 778 5,677
NET BOOK VALUE
At 31 March 2024 989 169 1,158
At 31 March 2023 907 329 1,236

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Other debtors 44,551 29,126

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 2,974 2,884
Taxation and social security 8,193 12,525
Other creditors 15,281 2,621
26,448 18,030

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2024 2023
£    £   
Bank loans 14,155 17,024

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal - 1,375

CROSSROADS CLINIC LTD (REGISTERED NUMBER: 09923907)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 March 2024 and 31 March 2023:

2024 2023
£    £   
Mrs S E Haycock
Balance outstanding at start of year 17,081 12,142
Amounts advanced 38,896 44,282
Amounts repaid (33,790 ) (39,343 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 22,187 17,081

Mrs E Protheroe
Balance outstanding at start of year 11,959 11,674
Amounts advanced 48,657 39,628
Amounts repaid (38,436 ) (39,343 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 22,180 11,959

Included in other debtors is an amount of £44,367.54 (2023: £29,040.58) which is owed by the directors. This amount will be repaid within nine months of the year end.